René Medema
We have been using the complete DNA test for the past two years in the routine care of patients with cancer. The test provides at least as much, and often more, information we can use to treat our patients than regular tests. Moreover, in patients with an unknown primary tumor, it can help us to diagnose the cancer and find a treatment. This test also makes a difference for patients with a sarcoma. Our researchers have scientifically demonstrated this in several studies.
Back to newsMore news
Erasmus MC Cancer Institute introduces comprehensive DNA testing for CUP cancer patients in EMBRAZE region
The Erasmus MC Cancer Institute has started using comprehensive DNA testing for carcinoma of unknown primary (CUP) cancer patients in …
Catalog makes Hartwig Medical Database easily searchable
Hartwig Medical Foundation maintains a catalog of the Hartwig Medical Database with whole-genome data on full tumor genomes: https://catalog.hartwigmedicalfoundation.nl. The …
Patients can benefit from whole genome sequencing for immunotherapy
Immunotherapy is an effective treatment for many people with cancer. The number of abnormalities in the DNA of the tumor in …
I know how important knowledge of hereditary predisposition to cancer can be. This is why I think it is so important that comprehensive patient reports include precisely that carrier information, if the patient wishes to be informed of it.